GET THE APP
Cancer Immuno Therapy Top Journals | Open Access Journals
Cancer Science & Therapy

Cancer Science & Therapy

ISSN: 1948-5956

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Cancer Immuno Therapy Top Journals

Disease immunotherapy is an approved and fundamentally significant methodology for rewarding patients with malignancy. Given the tremendous research and clinical examination endeavors devoted to progressing both endogenous and engineered immunotherapy draws near, there is a need to concentrate on pivotal inquiries and characterize barriers to the essential understanding and clinical advancement. Here, we characterize ten key difficulties confronting malignant growth immunotherapy, which extend from absence of trust in making an interpretation of pre-clinical discoveries to recognizing ideal blends of resistant based treatments for some random patient. Tending to these difficulties will require the joined endeavors of fundamental scientists and clinicians, and the centering of assets to quicken comprehension of the perplexing cooperation among malignant growth and the resistant framework and the advancement of improved treatment alternatives for patients with disease.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 5332

Cancer Science & Therapy received 5332 citations as per Google Scholar report

Citation image
Cancer Science & Therapy peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment
Advances in NKT cell Immunotherapy for Glioblastoma.

View More »

 

Open Access Journals

arrow_upward arrow_upward